Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats

T. Kinouchi(Tokushima University), Shinji Nagahiro(Tokushima University)
Translational Stroke Research
November 6, 2017
Cited by 28


Related Papers